Latest 3 stories · newest Jul 15, 2026
Aspira Women's Health entered a Subordinated Business Loan Agreement with Agile Capital Funding, LLC effective July 1, 2026. The financing provides capital to support the company's operational needs and working capital.
Aspira Women's Health Inc. filed a warrant agreement allowing holders to purchase common stock between June 5, 2026 and June 5, 2029. The warrant issuance is a financing mechanism that provides the company with capital flexibility while offering investors equity upside potential.
Aspira Women's Health Inc. has entered into a Master Collaboration and License Agreement with The Cleveland Clinic Foundation for biomedical research and development projects in women's health diagnostics. The partnership leverages CCF's research capabilities and Aspira's diagnostic expertise to adv…
The same AWHL feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/AWHL/newsSTART FREE